Published in J Clin Oncol on January 01, 2001
Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study. Ann Intern Med (2016) 1.54
Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev (2011) 1.50
Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required? Pediatr Blood Cancer (2015) 1.41
Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer. Int J Cardiovasc Imaging (2009) 1.38
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine (2007) 1.37
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat Genet (2015) 1.22
Exercise interventions in children with cancer: a review. Int J Pediatr (2011) 1.10
Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev Hematol (2011) 1.07
Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol (2013) 1.07
Adult life after surviving lymphoma in childhood. Support Care Cancer (2008) 1.04
Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies. Cancer Epidemiol Biomarkers Prev (2008) 1.00
Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity. Cell Death Dis (2011) 0.98
Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons. J Biol Chem (2012) 0.96
Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis. Br J Haematol (2009) 0.92
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol (2012) 0.91
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol (2016) 0.91
The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer. Eur J Pediatr (2003) 0.90
Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone. Invest New Drugs (2007) 0.89
Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort). Int J Epidemiol (2014) 0.89
Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med (2015) 0.87
How does doxorubicin work? Elife (2012) 0.83
Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. Eur J Pediatr (2013) 0.82
Cancer cell response to anthracyclines effects: mysteries of the hidden proteins associated with these drugs. Int J Mol Sci (2012) 0.81
Cardiovascular toxicities from systemic breast cancer therapy. Front Oncol (2014) 0.81
Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect? Eur J Pediatr (2006) 0.80
Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines. J Exp Clin Cancer Res (2012) 0.80
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors. Cancer (2016) 0.79
Risk factors for anthracycline-associated cardiotoxicity. Support Care Cancer (2015) 0.78
Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS). J Cancer Res Clin Oncol (2005) 0.78
Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient. Clin Pediatr Emerg Med (2011) 0.78
Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways. Oncotarget (2015) 0.77
Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte. J Proteomics (2011) 0.77
Childhood to adult transition and long-term follow-up after blood and marrow transplantation. Bone Marrow Transplant (2015) 0.76
Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors. World J Cardiol (2014) 0.76
Dexrazoxane for the treatment of chemotherapy-related side effects. Cancer Manag Res (2014) 0.76
Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors. Pediatr Cardiol (2015) 0.76
The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study. Turk J Haematol (2014) 0.75
Gemcitabine induced cardiomyopathy: a case of multiple hit cardiotoxicity. ESC Heart Fail (2016) 0.75
Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study. BMC Cancer (2014) 0.75
Cardiac function in long-term survivors of childhood lymphoma. Cardiol Res Pract (2011) 0.75
Characteristics of patients with haematological and breast cancer (1996-2009) who died of heart failure-related causes after cancer therapy. ESC Heart Fail (2016) 0.75
Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Cell Death Dis (2017) 0.75
The differential effects of green tea on dose-dependent doxorubicin toxicity. Food Nutr Res (2015) 0.75
Towards a Model-Based Dose Recommendation for Doxorubicin in Children. Clin Pharmacokinet (2017) 0.75
Effect of dexrazoxane and amifostine on the vertebral bone quality of Doxorubicin treated male rats. Open Orthop J (2008) 0.75
Use of pattern recognition analysis to identify underlying relationships of Doxorubicin derivatives optimized for breast cancer treatment. ISRN Oncol (2011) 0.75
Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin Lymphoma - a commentary on report from Krull and colleagues. Transl Pediatr (2013) 0.75
NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors. Dis Markers (2015) 0.75
Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study. BMC Cancer (2017) 0.75
The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science (2001) 12.35
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J (2001) 4.85
Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol (2000) 4.15
[Favourable results with surgical treatment in 43 children with hypoplastic left-heart syndrome or similar disorders, 1999-2005]. Ned Tijdschr Geneeskd (2006) 2.89
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med (1996) 2.66
[Systematic review of the effects of therapy in infants with the KISS-syndrome (kinetic imbalance due to suboccipital strain)]. Ned Tijdschr Geneeskd (2005) 2.42
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Correction of atrioventricular septal defect. Results influenced by Down syndrome? Am J Dis Child (1989) 2.02
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol (2001) 2.01
Pneumococcal vaccination for the elderly in The Netherlands? Assessment of the quality and content of available comparative studies. Neth J Med (2004) 2.00
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol (1993) 1.88
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol (2002) 1.87
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol (1992) 1.79
Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. Am J Cardiol (1995) 1.69
Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.68
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer (2013) 1.65
Percutaneous balloon pulmonary valvuloplasty. Br Heart J (1985) 1.59
Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum (2006) 1.59
Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology (2004) 1.58
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation (1993) 1.55
Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet (1993) 1.55
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol (2012) 1.54
Repair of tricuspid atresia in 100 patients. J Thorac Cardiovasc Surg (1983) 1.54
Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol (2002) 1.50
Right ventricular hypertrophy and diastolic dysfunction in arterial switch patients without pulmonary artery stenosis. Heart (2007) 1.50
Meta-analysis of elective high frequency ventilation in preterm infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed (1999) 1.49
Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy. Eur J Cancer (2000) 1.48
Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet (1995) 1.45
Surgery for membranous subaortic stenosis. Long-term follow-up. Eur J Cardiothorac Surg (1993) 1.41
Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics (1999) 1.40
[Serious concerns regarding research linking cot death with child day care]. Ned Tijdschr Geneeskd (2008) 1.38
Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev (2003) 1.37
Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands. Psychooncology (2003) 1.37
Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol (1993) 1.34
Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol (1993) 1.32
Quantification of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease. Am Heart J (1995) 1.28
Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol (1996) 1.23
Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child (2001) 1.23
The arterial switch operation. An eight-year experience. J Thorac Cardiovasc Surg (1986) 1.19
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer (1998) 1.17
Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer (2006) 1.14
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol (2001) 1.13
Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens. Med Pediatr Oncol (1992) 1.13
Lymph node invasion and prognosis in nephroblastoma. Cancer (1980) 1.13
Allelotype of pediatric rhabdomyosarcoma. Oncogene (1997) 1.13
Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol (2002) 1.12
Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. Eur J Cancer (2005) 1.12
Impaired cognition and schooling in adults with end stage renal disease since childhood. Arch Dis Child (2002) 1.11
Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med (1995) 1.11
Maternal hyperhomocysteinaemia is a risk factor for congenital heart disease. BJOG (2006) 1.10
Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol (2001) 1.10
Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease. Heart (2002) 1.10
Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol (1989) 1.08
Intralesional infiltration of corticosteroids in localized Langerhans' cell histiocytosis. J Pediatr Orthop (1993) 1.08
Myosin and myoglobin as tumor markers in the diagnosis of rhabdomyosarcoma. A comparative study. Am J Surg Pathol (1984) 1.07
Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res (2002) 1.07
Posttraumatic stress symptoms in adult survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.07
Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet (1997) 1.05
Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases. J Clin Epidemiol (2008) 1.05
1p36: every subband a suppressor? Eur J Cancer (1995) 1.05
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma. Eur J Cancer (1995) 1.05
Trilateral retinoblastoma. Lancet (1980) 1.05
Audit of 10 years of referrals for fetal echocardiography. Prenat Diagn (2011) 1.05
Development of the cardiac conduction tissue in human embryos using HNK-1 antigen expression: possible relevance for understanding of abnormal atrial automaticity. Circulation (1999) 1.04
The volume effect in paediatric oncology: a systematic review. Ann Oncol (2013) 1.04
Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine. J Nucl Med (1987) 1.04
Brom's three-patch technique for repair of supravalvular aortic stenosis. J Thorac Cardiovasc Surg (1999) 1.03
Long-term results after the Fontan operation for tricuspid atresia. Circulation (1987) 1.02
Long-term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. J Thorac Cardiovasc Surg (1994) 1.02
Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev (2000) 0.99
Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. J Gen Virol (1998) 0.99
High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol (2006) 0.99
Clustering of hypermethylated genes in neuroblastoma. Genes Chromosomes Cancer (2003) 0.98
Ifosfamide, mesna and vincristine in paediatric oncology. Cancer Treat Rev (1983) 0.98
Postsurgical course of patients with congenitally corrected transposition of the great arteries. Am J Cardiol (1999) 0.98
Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus. Hum Genet (1996) 0.97
No excess fatigue in young adult survivors of childhood cancer. Eur J Cancer (2003) 0.97
Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer (2007) 0.97
One stage repair of aortic arch anomalies and intracardiac defects. Eur J Cardiothorac Surg (1991) 0.96
A new diagnostic approach to vascular rings and pulmonary slings: the role of MRI. Magn Reson Imaging (1998) 0.94
Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol (2007) 0.94
Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol (1990) 0.94
Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev (2007) 0.93
The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability. J Cancer Surviv (2013) 0.93
Bilateral Wilms' tumor: long-term survival and some epidemiological features. J Clin Oncol (1989) 0.93
Plasma renin activity in Wilms' tumour. Acta Endocrinol (Copenh) (1971) 0.92
The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis. Cancer Lett (2003) 0.92
Variability in management of symptomless microhaematuria in schoolchildren. Postgrad Med J (1998) 0.92
Surgical repair of aortopulmonary window: thirty-seven years of experience. Pediatr Cardiol (2006) 0.92
ECG predictors of ventricular arrhythmias and biventricular size and wall mass in tetralogy of Fallot with pulmonary regurgitation. Heart (2002) 0.91
Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol (2007) 0.91
Prognostic factors in surgery for pulmonary metastases in children. Surgery (1994) 0.91
Kawasaki disease: a maturational defect in immune responsiveness. J Infect Dis (1999) 0.90
[Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988]. Ned Tijdschr Geneeskd (1993) 0.90
Creatine kinase subunits M and B as markers in the diagnosis of poorly differentiated rhabdomyosarcomas in children. Hum Pathol (1985) 0.90